31 Jul 2009

UCB progress: new product launches and financials on track

Read More
24 Jul 2009

UCB receives CHMP positive opinion on Keppra® for infants and young children with partial-onset epilepsy

Read More
30 Jun 2009

UCB and Biogen Idec discontinue Phase II clinical trial of CDP323

Read More
29 Jun 2009

UCB brings Neupro® back to all patients in Europe

Read More
26 Jun 2009

Cimzia®, the only PEGylated anti-TNF, recommended for approval in the EU for rheumatoid arthritis

Read More
24 Jun 2009

Jazz Pharmaceuticals and UCB announce second Phase III study of sodium oxybate in patients with fibromyalgia meets primary endpoints

Read More
15 Jun 2009

UCB and PatientsLikeMe partner to give people with epilepsy a voice in advancing research

Read More
29 May 2009

UCB receives CHMP positive opinion on bringing Neupro® back to all patients in Europe

Read More
26 May 2009

UCB launches Vimpat® in the U.S. for add-on treatment of epilepsy in adults

Read More
20 May 2009

Change in UCB's Executive Committee

Read More
Subscribe to